NCT02858271View on ClinicalTrials.gov

Study to Assess the Absorption, Metabolism, Excretion and Pharmacokinetics of [14C]-AKB-9778

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Healthy
Interventions
DRUG

AKB-9778 subcutaneous injection

Sponsors
All Listed Sponsors
lead

Aerpio Therapeutics

INDUSTRY

NCT02858271 - Study to Assess the Absorption, Metabolism, Excretion and Pharmacokinetics of [14C]-AKB-9778 | Biotech Hunter | Biotech Hunter